مصطلحات الفهرس: controlled study, demography, disease registry, ethnic difference, family history, female, gastrointestinal disease, genetic variability, hemodialysis, hemolytic uremic syndrome/dt [Drug Therapy], human, kidney disease/su [Surgery], kidney disease/th [Therapy], kidney graft, kidney transplantation, major clinical study, complement factor H/ec [Endogenous Compound], Caucasian, clinical feature, cohort analysis, priority journal, sex difference, trend study, cardiovascular disease, eculizumab/dt [Drug Therapy], adult, age distribution, article, Australian, autoimmune disease, male, malignant neoplasm, medical history, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29108Test
Nephrology
LibKey Link

مصطلحات الفهرس: complement factor H/ec [Endogenous Compound], eculizumab/dt [Drug Therapy], heparin/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], lipocortin 5/ec [Endogenous Compound], low molecular weight heparin/dt [Drug Therapy], phosphatidylinositol 3 kinase/ec [Endogenous Compound], rituximab/dt [Drug Therapy], plasmapheresis, anticoagulant therapy, antiphospholipid syndrome/dt [Drug Therapy], antiphospholipid syndrome/et [Etiology], antiphospholipid syndrome/th [Therapy], complement activation, complement deposition, conformational transition, human, immunopathogenesis, immunosuppressive treatment, immunotherapy, priority journal, review, syncytiotrophoblast, complement component C5a/ec [Endogenous Compound], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38810Test
Internal Medicine Journal
Click here for full text options
LibKey Link

مصطلحات الفهرس: hemolytic uremic syndrome/th [Therapy], hemolytic uremic syndrome/dt [Drug Therapy], human, kidney biopsy, lethargy/co [Complication], maintenance therapy, male, malignant hypertension/co [Complication], malignant hypertension/dt [Drug Therapy], nausea/co [Complication], nonhuman, Norovirus, plasmapheresis, relapse, review, seizure/co [Complication], thrombocyte count, thrombocytopenia/di [Diagnosis], thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/th [Therapy], treatment duration, urea blood level, vomiting, complement factor H/ec [Endogenous Compound], creatinine/ec [Endogenous Compound], eculizumab/dt [Drug Therapy], haptoglobin/ec [Endogenous Compound], hemoglobin/ec [Endogenous Compound], labetalol/dt [Drug Therapy], lactate dehydrogenase/ec [Endogenous Compound], lercanidipine/dt [Drug Therapy], ramipril/dt [Drug Therapy], von Willebrand factor cleaving proteinase/ec [Endogenous Compound], complement factor H gene, fecal shiga toxin test, helmet cell, acute kidney failure/di [Diagnosis], adult, case report, cells, diarrhea, erythrocyte, erythrocyte disorder, family history, feces analysis, gene mutation, genetic screening, headache/co [Complication], hematuria/di [Diagnosis], hemodialysis, hemolysis, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39530Test
Nephrology
Click here for full text options
LibKey Link

مصطلحات الفهرس: complement factor H/ec [Endogenous Compound], eculizumab/dt [Drug Therapy], heparin/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], lipocortin 5/ec [Endogenous Compound], low molecular weight heparin/dt [Drug Therapy], phosphatidylinositol 3 kinase/ec [Endogenous Compound], rituximab/dt [Drug Therapy], plasmapheresis, anticoagulant therapy, antiphospholipid syndrome/dt [Drug Therapy], antiphospholipid syndrome/et [Etiology], antiphospholipid syndrome/th [Therapy], complement activation, complement deposition, conformational transition, human, immunopathogenesis, immunosuppressive treatment, immunotherapy, priority journal, review, syncytiotrophoblast, complement component C5a/ec [Endogenous Compound], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38810Test
Internal Medicine Journal
Click here for full text options
LibKey Link

مصطلحات الفهرس: hemolytic uremic syndrome/th [Therapy], hemolytic uremic syndrome/dt [Drug Therapy], human, kidney biopsy, lethargy/co [Complication], maintenance therapy, male, malignant hypertension/co [Complication], malignant hypertension/dt [Drug Therapy], nausea/co [Complication], nonhuman, Norovirus, plasmapheresis, relapse, review, seizure/co [Complication], thrombocyte count, thrombocytopenia/di [Diagnosis], thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/th [Therapy], treatment duration, urea blood level, vomiting, complement factor H/ec [Endogenous Compound], creatinine/ec [Endogenous Compound], eculizumab/dt [Drug Therapy], haptoglobin/ec [Endogenous Compound], hemoglobin/ec [Endogenous Compound], labetalol/dt [Drug Therapy], lactate dehydrogenase/ec [Endogenous Compound], lercanidipine/dt [Drug Therapy], ramipril/dt [Drug Therapy], von Willebrand factor cleaving proteinase/ec [Endogenous Compound], complement factor H gene, fecal shiga toxin test, helmet cell, acute kidney failure/di [Diagnosis], adult, case report, cells, diarrhea, erythrocyte, erythrocyte disorder, family history, feces analysis, gene mutation, genetic screening, headache/co [Complication], hematuria/di [Diagnosis], hemodialysis, hemolysis, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39530Test
Nephrology
Click here for full text options
LibKey Link